Broken redirects

The following redirects link to non-existent pages:

Showing below up to 100 results in range #1 to #100.

1. Bangui definition → 1985 World Health Organization AIDS surveillance case definition
2. C21-hydroxylase deficiency → 21-Hydroxylase Deficiency
3. Steroid 21-hydroxylase deficiency → 21-Hydroxylase Deficiency
4. Steroid 21-monooxygenase deficiency → 21-Hydroxylase Deficiency
5. MAVErIC II → 30-Day Results From A Prospective Registry Of Carotid Stenting With The Exponent Stent And Distal Protection With The Guardwire In High Risk Patients
6. 48,XXYY syndrome → 48 XX,YY
7. 48 xxyy syndrome → 48 XX,YY
8. ACT-UP → AIDS Coalition to Unleash Power
9. ASTM → ASTM International
10. ABSORB: 6-month and 2-year results → A Bioabsorbable Everolimus-Eluting Coronary Stent System For Patients With Single De-Novo Coronary Artery Lesions
11. PREPIC → A Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
12. Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus → A Comparison Of Ibuprofen And Indomethacin For Closure Of Patent Ductus Arteriosus
13. THESEE → A Comparison Of Low-Molecular-Weight Heparin With Unfractionated Heparin For Acute Pulmonary Embolism
14. TOPAS → A Comparison Of Recombinant Urokinase With Vascular Surgery As Initial Treatment For Acute Arterial Occlusion Of The Legs
15. CRIS → A Controlled Trial Of Verapamil In Patients After Acute Myocardial Infarction: Results Of The Calcium, Antagonist Reinfarction Italian Study
16. ACCENT → A Crohn's Disease Clinical Trial Evaluating Infliximab In A New Long-Term Treatment Regimen
17. AGENT-3 → A Multicenter, Prospective, Randomized Trial Of Intracoronary Administration Of Ad5Fgf-4 In Patients With No Revascularization Options
18. MINT → A Multicenter, Randomized Study Of Argatroban Versus Heparin As Adjunct To Tissue Plasminogen Activator (Tpa) In Acute Myocardial Infarction: Myocardial Infarction With Novastan And Tpa (Mint) Study
19. AMAZE → A Multicenter Trial Using-Zestril Versus To Evaluate The Effects On Lowering Blood Pressure
20. PRIDE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
21. CAPTIVE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Third Generation Mednova Emboshield Compared To The Guardwire Or Filterwire
22. DIABETES → A Prospective, Randomized, Controlled Trial Of The Polymer-Based, Sirolimus-Eluting Stent Versus A Bare Metal Stent In Patients With Diabetes Mellitus
23. AiMI → A Prospective, Randomized, Controlled Trial Of Thrombectomy With The Angiojet In Acute Myocardial Infarction
24. RACTS → A Prospective, Randomized Multicenter Trial Of Cilostozal Vs Ticlopidine In Patients Undergoing Stent Implantation
25. REDUCE III → A Prospective, Randomized Multicenter Trial Of Cutting Balloon Before Stenting In Patients Undergoing Pci
26. SYMBIOT III → A Prospective, Randomized Trial Of A Self-Expanding Ptfe Stent Graft During Svg Intervention - Late Results
27. SYNERGY-PCI → A Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention
28. GENESIS → A Randomized, Multicenter Study Of The Pimecrolimus-Eluting And Pimecrolimus/Paclitaxel-Eluting Coronary Stent System In Patients With De Novo Lesions Of The Native Coronary Arteries
29. RAVEL → A Randomized Comparison Of A Sirolimus-Eluting Stent With A Standard Stent For Coronary Revascularization
30. GENIUS-STEMI → A Randomized Comparison Of Genous Stent Versus Chromium-Cobalt Stent For Treatment Of St-Elevation Myocardial Infarction
31. DES-DIABETES → A Randomized Comparison Of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation In Patients With Diabetes Mellitus
32. ADVANCE → A Randomized Comparison Of The Value Of Additional Stenting After Optimal Balloon Angioplasty For Long Coronary Lesions
33. RIO-Europe → A Randomized Double-Blind Study Of Weight Reducing Effect And Safety Of Rimonabant In Obese Patients With Or Without Comorbidities
34. SPIRIT → A Randomized Trial Of Anticoagulants Versus Aspirin After Cerebral Ischemia Of Presumed Arterial Origin
35. STAR → A Randomized Trial Of Recombinant Staphylokinase Versus Altepase For Coronary Artery Patency In Acute Myocardial Infarction
36. SMARTT → A Randomized Trial Of The Effects Of Early Cardiac Serum Marker Availability On Reperfusion Therapy In Patients With Acute Myocardial Infarction. The Serial Markers, Acute Myocardial Infarction And Rapid Treatment Trial (Smartt)
37. INTERHEART → A Study Of Risk Factors For First Myocardial Infarction In 52 Countries And Over 27,000 Subjects
38. ASTEROID → A Study To Evaluate The Effect Of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden
39. AURORA → A Study To Evaluate The Use Of Rosuvastatin In Subjects On Regular Hemodialysis: An Assessment Of Survival And Cardiovascular Events
40. Tubulidentata → Aardvark
41. Aaron Beck → Aaron Temkin Beck
42. AbESTT → Abciximab Emergent Stroke Treatment Trial
43. APAF → Ablation For Paroxysmal Atrial Fibrillation (Apaf) Trial
44. Abraham De Moivre → Abraham de Moivre
45. Abulcasis → Abu al-Qasim al-Zahrawi
46. Al-Zahrawi → Abu al-Qasim al-Zahrawi
47. ACTIVATE → Acat Inhibition On The Progression Of Coronary Atherosclerosis
48. Access Site Complications → Access site complications
49. ASTRONAUT → Acid Suppression Trial: Ranitidine Zantac Versus Omeprazole
50. Acinetobacter spp → Acinetobacter
51. ATLAS - SVG → Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts
52. Acquired pure megakaryocytic aplasia → Acquired pure red cell aplasia
53. ASCENT → Acs Stent Clinical Equivalence In De Novo Lesions Trial
54. ACTIV in CHF → Acute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure
55. ACCESS → Acute Candesartan Cilexetil Evaluation In Stroke Survivors
56. ACUITY Timing Trial → Acute Catheterization And Urgent Intervention Triage Strategy Timing Trial
57. ACUITY PCI: 30-day and 1-Year Results → Acute Catheterization And Urgent Intervention Triage Strategy Trial - Pci Subgroup: 30-Day And 1-Year Results
58. AIRE → Acute Infarction Ramipril Efficacy Study
59. AIST-ASH → Acute Ischemic Stroke Trial: Oral Aspirin Vs Intravenous Heparin On Stroke Progression
60. AMISTAD → Acute Myocardial Infarction Study Of Adenosine
61. AMISTAD II → Acute Myocardial Infarction Study Of Adenosine II
62. AMISTAD I → Acute Myocardial Infarction Study Of Adenosine Trial
63. AMIHOT → Acute Myocardial Infarction With Hyperoxemic Therapy
64. AMIHOT II → Acute Myocardial Infarction With Hyperoxemic Therapy II
65. Acute biphenotypic leukemia → Acute biphenotypic leukaemia
66. FEMINA → Addition Of Felodipine To Metoprolol Vs. Replacement Of Metoprolol By Felodipine In Patients With Angina Pectoris Despite Adequate Beta-Blockade
67. Adenoid cystic cancer → Adenoid cystic carcinoma
68. Adenocyst → Adenoid cystic carcinoma
69. Malignant cylindroma → Adenoid cystic carcinoma
70. Adenocystic carcinoma → Adenoid cystic carcinoma
71. Adenoidcystic carcinoma → Adenoid cystic carcinoma
72. Cribriform Carcinoma → Adenoid cystic carcinoma
73. Toxic thyroid adenoma → Adenoma of the thyroid
74. INSPIRE → Adenosine Sestamibi Post-Infarction Evaluation (Inspire) Trial
75. ADEMEX → Adequacy Of Peritoneal Dialysis In Mexico
76. ABACAS → Adjunctive Balloon Angioplasty Following Coronary Atherectomy Study
77. Adolf Windaus → Adolf Otto Reinhold Windaus
78. Adrien Marie Legendre → Adrien-Marie Legendre
79. AGIS → Advanced Glaucoma Intervention Study
80. Advocacy → Advocate
81. AIR → Aerosolized Iloprost Randomized Placebo-Controlled Study
82. A-HeFT → African-American Heart Failure Trial
83. A to Z, Phase A → Aggrastat To Zocor
84. AtoZ → Aggrastat To Zocor Study
85. Aggressiveness → Aggression
86. ALLIANCE → Aggressive Lipid-Lowering Initiation Abates New Cardiac Events
87. ARISE → Aggressive Reduction Of Inflammation Stops Events
88. Intermediate-grade lymphoma → Aggressive lymphoma
89. High-grade lymphoma → Aggressive lymphoma
90. Aging in Place → Aging in place
91. Redtop grass → Agrostis gigantea
92. Alcoholic beverages → Alcoholic beverage
93. Aldactone Antagonists → Aldactone antagonist
94. Lemtrada → Alentuzumab
95. Immortality Device → Alex Chiu
96. Edmé Félix Alfred Vulpian → Alfred Vulpian
97. ALLAY → Aliskiren In Left Ventricular Hypertrophy
98. AVOID → Aliskiren In The Evaluation Of Proteinuria In Diabetes
99. ALOFT → Aliskiren Observations Of Heart Failure Treatment
100. ATBC → Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study